Studying therapeutics is important to understand and develop treatments for diseases and improve patient outcomes. It helps in advancing medical knowledge, discovering new drugs, and improving existing therapies. Additionally, studying therapeutics is crucial for developing personalized medicine approaches that target individual patient needs.
This report is a comprehensive study of the global market for epigenetic therapeutics. It describes the Epigenetic Therapeutics Market, which is segmented by product type and region.
Bernhard Baehr has written: 'The science of therapeutics' -- subject(s): Therapeutics, Homeopathy 'The science of therapeutics' 'The science of therapeutics' -- subject(s): Homeopathy 'The science of therapeutics according to the principles of homoeopathy' -- subject(s): Therapeutics, Homeopathy
Arthur Grollman has written: 'The measurement of osmotic pressure and its application to a study of aqueous phenol solutions..' -- subject(s): Osmosis, Phenols, Solution (Chemistry) 'Pharmacology and therapeutics' -- subject(s): Therapeutics, Pharmacology 'Pharmacology and therapeutics' -- subject(s): Pharmacology, Therapeutics 'Clinical endocrinology and its physiologic basis' -- subject(s): Diseases, Endocrine glands 'The functional pathology of disease'
IL Therapeutics was created in 2005.
Acorda Therapeutics was created in 1995.
The population of Acorda Therapeutics is 220.
The population of Regulus Therapeutics is 54.
Silence Therapeutics was created in 1994.
The population of Silence Therapeutics is 50.
Edge Therapeutics was created in 2009.
Prime Therapeutics was created in 1998.
The population of Prime Therapeutics is 2,011.